id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-317552-hyyw6eln	Huette, Pierre	Extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: outcome and time-course of clinical and biological parameters	2020-06-01		.txt	text/plain	596	47	47	title: Extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: outcome and time-course of clinical and biological parameters The place of extracorporeal membrane oxygenation (ECMO) therapy in the coronavirus disease 2019 (COVID-19) outbreak is undefined. We report a prospective caseseries that describes the clinical course of patients with COVID-19 with respiratory failure requiring veno-venous ECMO between March 2020 and April 2020. After ethical approval, we prospectively collected data on consecutive COVID-19 patients (confirmed with reverse transcription polymerase chain reaction testing) admitted to our referral centre for ECMO therapy. In this case-series of patients with COVID-19-related respiratory failure, we found a high rate of ECMOweaning. A high risk of thrombosis for COVID-19 patients under ECMO has been suggested previously. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study	./cache/cord-317552-hyyw6eln.txt	./txt/cord-317552-hyyw6eln.txt